Back to Journals » Drug Design, Development and Therapy » Volume 16
Review
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Expanding the Clinical Use of CDK4/6 Inhibitors in the Treatment of Hormone Receptor-Positive, HER2-Negative Breast Cancer from Metastatic Setting to Adjuvant Setting
Total article views | HTML views | PDF downloads | Totals | ||
---|---|---|---|---|---|
9,197 | Dovepress* | 7,083+ | 427 | 7,510 | |
PubMed Central* | 2,114 | 488 | 2,602 | ||
Totals | 9,197 | 915 | 10,112 | ||
*Since 16 March 2022 |
View citations on PubMed Central and Google Scholar